Barclays’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Sell
847,781
-165,175
-16% -$972K ﹤0.01% 1812
2026
Q1
$4.48M Buy
1,012,956
+506,168
+100% +$2.99M ﹤0.01% 1884
2025
Q4
$2.71M Buy
506,788
+274,424
+118% +$2.18M ﹤0.01% 2708
2025
Q3
$2.24M Buy
232,364
+56,416
+32% +$520K ﹤0.01% 2810
2025
Q2
$1.29M Buy
175,948
+91,407
+108% +$613K ﹤0.01% 3160
2025
Q1
$396K Sell
84,541
-23,416
-22% -$117K ﹤0.01% 3665
2024
Q4
$489K Buy
107,957
+35,627
+49% +$190K ﹤0.01% 3842
2024
Q3
$201K Buy
72,330
+58,897
+438% +$157K ﹤0.01% 4278
2024
Q2
$41.1K Buy
+13,433
New +$51.8K ﹤0.01% 4287

Other funds holding ASPI

Barclays's ASPI Position: Q2 2026 in Review

Barclays reduced its ASP Isotopes (ASPI) stake by 16% in Q2 2026, selling an estimated $972K and leaving 847,781 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Barclays first reported a position in ASPI in Q2 2024 and has held it in 9 quarters since. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Barclays held 847,781 shares of ASP Isotopes worth $5.27M as of Q2 2026.
  • Barclays sold 165,175 ASP Isotopes shares in Q2 2026, an estimated $972K.
  • ASP Isotopes made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1812 holding.
  • Barclays first reported a position in ASP Isotopes in Q2 2024 and has held it in 9 quarters since.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.